Cell Cycle

Items 351-387 of 387

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. DNA G-quadruplexe (G4) ligand

    BMVC-8C3O is a DNA G-quadruplexe (G4) ligand which can induce topological conversion of non-parallel to parallel forms in human telomeric DNA G4s.
  2. CDK inhibitor

    GW779439X is an inhibitor of cyclin dependent kinase.
  3. E3 ligase activity inhibitor

    Apcin, a ligand of Cdc20, is a potent and competitive anaphase-promoting complex/cyclosome (APC/C(Cdc20)) E3 ligase activity inhibitor.
  4. inhibitor of Ral binding to RALBP1

    RBC10 is an inhibitor of Ral binding to RALBP1 (the effector).
  5. Nur77/NR4A1 agonist

    Cytosporone B (Csn-B; Dothiorelone G) is a naturally occurring nuclear orphan receptor Nur77/NR4A1 agonist with an EC50 of 0.278 nM.
  6. CHKα inhibitor

    MN58b is a selective choline kinase α (CHKα) inhibitor, and results in inhibition of phosphocholine synthesis.
  7. ATP-competitive CHK1 inhibitor

    Prexasertib (LY2606368) is an ATP-competitive CHK1 inhibitor with a Ki value of 0.9 nmol/L. For CHK2 and RSK, its IC50 values are 8 nM and 9 nM respectively in cell-free assay.
  8. CDK9 inhibitor

    JSH-150 is a highly selective and potent CDK9 inhibitor with an IC50 of 1 nM.
  9. ATP-competitive CDK2 and CDK5 inhibitor

    PNU112455A hydrochloride is an ATP-competitive CDK2 and CDK5 inhibitor.
  10. LIMK inhibitor

    TH-263 is an inactive analog control for the type III allosteric LIM-kinase (LIMK) inhibitors TH-257, TH-255 and TH-251.
  11. anaphase-promoting complex (APC) inhibitor

    Apcin-A, an Apcin derivative, is an anaphase-promoting complex (APC) inhibitor.
  12. PLK4 inhibitor

    CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.
  13. Rho family GTPases inhibitor

    MLS000532223 is a high affinity, selective inhibitor of Rho family GTPases, with EC50 values ranging from 16 μM to 120 μM.
  14. PKs inhibitor

    HA-100 is an isoquinoline compound with an added piperazinylsulfonyl group that acts as an inhibitor of protein kinases (PKs), including PKA, PKC, and PKG (IC50s = 8, 12, and 4 ?M, respectively).
  15. CDK4/6 inhibitor

    Ribociclib hydrochloride (LEE011 hydrochloride) is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively,
  16. CDK8/CDK19 inhibitor

    BRD6989 is a selective inhibitor of CDK8 and CDK19. BRD6989 upregulates IL-10. BRD6989 is an analog of the natural product cortistatin A (dCA).
  17. LIMK1/LIMK2 inhibitor

    TH-257 is a potent inhibitor of LIMK1 and LIMK2 with IC50 values of 84 nM and 39 nM for LIMK1 and LIMK2, respectively, and it can be used as a chemical probe for LIMK1 and LIMK2.
  18. CDK6 degrader

    BSJ-03-123 is a potent and novel CDK6-selective small-molecule degrader (PROTAC).
  19. dual inhibitor of CDK12/CDK13

    SR-4835 is a potent, highly selective and ATP competitive dual inhibitor of CDK12/CDK13 (CDK12: IC50=99 nM, Kd=98 nM; CDK13: Kd=4.9 nM).
  20. CDK8 and CDK19 inhibitor

    AS2863619 is a potent, orally active cyclin-dependent kinase 8 (CDK8) and CDK19 inhibitor with IC50s of 0.61 nM and 4.28 nM, respectively.
  21. MRTF pathway inhibitor

    CCG-222740 is an orally active and selective Rho/myocardin-related transcription factor (MRTF) pathway inhibitor. CCG-222740 is also a potent inhibitor of alpha-smooth muscle actin protein expression.
  22. dual inhibitor of protein kinase and CDK

    6-(Dimethylamino)purine is a dual inhibitor of protein kinase and CDK.
  23. CHK1 inhibitor

    SAR-020106 is an ATP-competitive, potent, and selective CHK1 inhibitor with an IC50 of 13.3 nM for human CHK1.
  24. covalent ligand

    EN4 is a covalent ligand that targets cysteine 171 (C171) of MYC. EN4 is selective for c-MYC over N-MYC and L-MYC. EN4 inhibits MYC transcriptional activity, downregulates MYC targets, and impairs tumorigenesis.
  25. NR4A1 antagonist

    DIM-C-pPhOH is a nuclear receptor 4A1 (NR4A1) antagonist.
  26. MYC inhibitor

    MYCi361 (NUCC-0196361) is a MYC inhibitor with the Kd of 3.2 μM for binding to MYC. MYCi361 (NUCC-0196361) suppresses tumor growth and enhances anti-PD1 immunotherapy.
  27. MYC inhibitor

    MYCi975 (NUCC-0200975) is an orally active MYC inhibitor, which disrupts MYC/MAX interaction, promotes MYC T58 phosphorylation and MYC degradation, and impairs MYC driven gene expression.
  28. G-quadruplex DNA Stabilizer

    Pyridostatin stabilizes G-quadruplexes (G4s) in cells and elicits a DNA damage response by causing the formation of DNA double strand breaks (DSB).
  29. PLK4 inhibitor

    CFI-400437 is a potent and selective inhibitor of polo-like kinase 4 (PLK4).
  30. protein-protein interactions inhibitor

    NSC-92828, also known as 3-Phenanthrenebutyric acid, is a Protein-protein interaction inhibitor (PP inhibitor or PPI).

  31. RAD51 inhibitor

    Bractoppin is a potent and selective inhibitor of phosphopeptide recognition by the BRCA1 tBRCT domain.
  32. S-IIP inhibitor/KRASG12C Probe

    ARS-1323-Alkyne is a novel KRASG12C occupancy probe.
  33. MYC:MAX protein interactions inhibitor

    MYCMI-6 (NSC354961) is a potent and selective endogenous MYC:MAX protein interactions inhibitor.
  34. mono-stryryl dye

    2-Di-1-ASP (Compound 18a) is a mono-stryryl dye, and widely used as mitochondrial stain and groove-binding fluorescent probes for double-stranded DNA. 2-Di-1-ASP is selective for G-quadruplex (G4) and double-stranded DNA.
  35. Anaphase Promoting Complex Subunit 13 Human Recombinant
  36. ATF6α inhibitor

    Ceapin-A7 is a selective blocker of ATF6α signaling in response to ER stress, with an IC50 of 0.59 μM. 

  37. c-Myc Peptide (TFA) is a synthetic peptide corresponding to the C-terminal amino acids (410-419) of human c-myc protein, and participates in regulation of growth-related gene transcription.

Items 351-387 of 387

Page
per page
Set Descending Direction